All sars-cov-2 articles – Page 2
-
NewsFirst Covid-19 challenge study working with live virus planned for the UK
Pending ethics panel approval, healthy volunteers would be infected with Sars-CoV-2 to help understand disease and test vaccines
-
NewsNew Covid-19 test doesn’t need reagents that are in short supply
US researchers develop a two-step test for the novel coronavirus that doesn’t requires the use of scarce reagents
-
BusinessProtein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
NewsRush to approve Covid vaccine prompted by politics may end in disaster
Push by governments to pass a vaccine without appropriate evidence could damage fight against virus
-
NewsHand-powered centrifuge setup can diagnose Covid-19 for just a dollar a test
$5 centrifuge based on children’s toy part of raft of cheap technologies that can detect the virus in saliva in remote locations
-
NewsDoes hydroxychloroquine still have a role to play in this pandemic?
Touted as a wonder drug by some its star now appears to be on the wane
-
NewsExplainer: The science of Covid-19 testing
Rapidly-deployed methods are saving lives and easing minds
-
NewsExplainer: how is the vaccine pipeline for Covid-19 looking?
The race to develop a vaccine is almost six months old. Who’s in the lead?
-
ResearchRespiratory viruses detected in 30 minutes with the help of a smartphone
$50 smartphone accessory could be adapted for Covid-19
-
BusinessDeveloping antiviral mask technology in a pandemic
Surface chemistry strategies play a pivotal role in personal protective equipment that can neutralise the Sars-CoV-2 virus
-
ResearchNanoparticle antivirals offer new way to fight coronaviruses but therapy is still in its infancy
Antiviral platform can be tailored to a wide range of viruses by chemical modification
-
NewsVaccine manufacturing centre to be rushed into service a year early by UK government
Injection of new funding will mean centre opens in 2021 as licensing deal also agreed to boost vaccine capabilities
-
NewsCovid-19 wreaks havoc on US universities leaving their finances in disarray
The pandemic has led to S&P Global slashing the outlook for 127 US colleges and universities
-
NewsEfforts to combat Covid-19 in India hit by imported reagent shortages
Low testing rates and supply problems have led to a search for alternatives
-
NewsScholarly publishers join forces to fast-track Covid-19 studies
Researchers asked to volunteer as ‘rapid reviewers’ for coronavirus manuscripts, and over 1000 have already answered the call
-
NewsSpanish universities plan phased return in June as number of Covid-19 cases slows
Goal is to minimise disruption to students and researchers without putting anyone at unnecessary risk
-
NewsScience steps up a gear as struggle to both understand and fight coronavirus intensifies
Research that might have taken years is being turned around in months as journals fast-track Covid-19 manuscripts
-
NewsUK seeks to scale-up Covid-19 testing but large gaps in capabilities remain
Universities and research labs are being brought in to help with testing but 100,000 tests per day by the end of April still looks overly ambitious
-
NewsUK’s largest funder aims to raise $8 billion in three weeks for coronavirus research
The Wellcome Trust’s Covid-Zero initiative calls on businesses to bridge the funding shortfall
-
ResearchPotent coronavirus drug candidate designed using 3D structure of key viral enzyme
Inhibitor of Sars-CoV-2 protease shows promise in early animal tests
- Previous Page
- Page1
- Page2
- Page3
- Next Page